Skip Navigation



NDT Advance Access published online on April 6, 2005

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh814
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/7/1336    most recent
gfh814v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leung, J. C. K.
Right arrow Articles by Lai, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, J. C. K.
Right arrow Articles by Lai, K. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received October 14, 2004
Accepted March 8, 2005


Original Articles

Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF

Joseph C. K. Leung 1, Loretta Y. Y. Chan 1, Felix F. K. Li 1, Sydney C. W. Tang 1, Kwok Wa Chan 2, Tak Mao Chan 1, Man Fai Lam 1, Anders Wieslander 3, and Kar Neng Lai 1*

1 Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong
2 Department of Pathology, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong
3 Gambro AB, Lund, Sweden

* To whom correspondence should be addressed.
Kar Neng Lai, E-mail: knlai{at}hkucc.hku.hk



  Abstract

Background. Glucose degradation products (GDPs) are formed during heat sterilization of peritoneal dialysis fluid and, to a lesser extent, during their prolonged storage. In vitro studies have demonstrated that GDPs impair functions of peritoneal mesothelial cells, including proliferation, viability and cytokine release. In the present study, we studied the acute effect of GDPs on the expression of tight junction-associated protein, zonula occludens protein 1 (ZO-1), in human peritoneal mesothelial cells (HPMC). The role of the vascular endothelial growth factor (VEGF) induced by GDPs in the expression of ZO-1 was also examined.

Methods. HPMC were cultured with GDPs, including 2-furaldehyde (FurA), methylglyoxal (M-Glx) and 3,4-dideoxyglucosone-3-ene (3,4-DGE). The expression of ZO-1 and the synthesis of VEGF were examined. To define the role of VEGF on the regulation of ZO-1 expression, HPMC were cultured with GDPs in the presence or absence of neutralizing antibody to VEGF. The signal pathways involved in VEGF synthesis induced by GDPs were also characterized.

Results. ZO-1 expression in HPMC was downregulated in a time- and dose-dependent manner following culture with subtoxic concentrations of GDPs (FurA, M-Glx and 3,4-DGE). All three GDPs increased VEGF synthesis in HPMC. Exogenous VEGF downregulated the expression of ZO-1 and neutralizing anti-VEGF antibody reversed the effect of GDPs on ZO-1 expression in HPMC, suggesting the action of GDPs on ZO-1 expression was mediated by VEGF. All three GDPs activated the p42/p44 mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) signal transduction pathways. The GDP-induced VEGF and transforming growth factor (TGF)-{beta} synthesis in HPMC was partially reduced by either the p42/p44 MAPK inhibitor (PD98059) or the PKC inhibitor (staurosporine). More importantly, the VEGF and TGF-{beta} synthesis induced by GDPs in HPMC was completely blocked by synergistic action of both inhibitors.

Conclusions. We have demonstrated that short-term exposure to GDPs downregulates ZO-1 expression in HPMC through the generation of VEGF. Our study provides evidence that GDPs can directly induce VEGF and TGF-{beta} production in HPMC through the activation of p42/44 MAPK and PKC signal transduction pathways.

Keywords: glucose degradation products; peritoneal dialysis; peritoneal mesothelial cells; vascular endothelial growth factor; zonula occludens protein 1.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
R. Yanai, J.-A. Ko, N. Nomi, N. Morishige, T.-i. Chikama, A. Hattori, K. Hozumi, M. Nomizu, and T. Nishida
Upregulation of ZO-1 in Cultured Human Corneal Epithelial Cells by a Peptide (PHSRN) Corresponding to the Second Cell-Binding Site of Fibronectin
Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2757 - 2764.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Yamamoto, T. Tomo, E. Okabe, S. Namoto, K. Suzuki, and Y. Hirao
Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1436 - 1442.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
K. N. Lai, S. C.W. Tang, and J. C.K. Leung
MEDIATORS OF INFLAMMATION AND FIBROSIS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S65 - S71.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.